HCP Live June 24, 2024
Abigail Brooks, MA

Study results highlight the impact of continuous glucose monitoring on glucose control and HbA1c improvements in patients with type 2 diabetes, regardless of treatment regimen.

Findings from a recent study are calling attention to the significant impact of continuous glucose monitoring (CGM) on glucose control in patients with type 2 diabetes, highlighting its impact in this patient population across individuals on various therapeutic treatments.1

The research was presented at the 84th American Diabetes Association (ADA) Scientific Sessions and found CGM use was associated with significant hemoglobin A1C (HbA1c) improvements in both non-insulin and insulin-treated patients with type 2 diabetes after 12 months.1,2

“These results suggest that CGM can play a crucial role in enhancing health outcomes for all diabetes patients,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Conferences / Podcast, Digital Health, Patient / Consumer, Provider, Survey / Study, Technology, Trends, Wearables
Related Articles:
See how your body works in real time – wearable ultrasound is on its way
AI-powered wristband or fingertip clip may revolutionize sleep apnea diagnosis
Abbott and Dexcom are launching the first over-the-counter CGMs. Here are 7 questions on the new tech.
Wearable Technology: A Growing Industry Transforming Health and Wellness
Continuous Glucose Monitoring Can Aid Hospital Patients

Share This Article